Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 52% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 3 institutions in 2 countries.
Hongwei WanUniversité Paris Cité, CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France.ORCID 0000-0002-6906-3996
Raja Ben OthmanUniversité Paris Cité, CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France.
Laurent Le CorreUniversité Paris Cité, CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France.ORCID 0000-0002-0136-8072
Mélanie PoinsotUniversité Paris Cité, CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France.
Martin OliverUniversité Paris Cité, CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France.ORCID 0000-0002-3602-0228
Ana AmorosoUnité de Physiologie et Génétique Bactériennes, Centre d'Ingénierie des Protéines, Département des Sciences de la Vie, Université de Liège, Sart Tilman, B4000 Liège, Belgium.ORCID 0000-0002-9146-7364
Bernard JorisUnité de Physiologie et Génétique Bactériennes, Centre d'Ingénierie des Protéines, Département des Sciences de la Vie, Université de Liège, Sart Tilman, B4000 Liège, Belgium.
Thierry TouzéInstitute for Integrative Biology of the Cell (I2BC), CNRS, Université Paris Sud, CEA, F-91405 Orsay, France.
Rodolphe AugerInstitute for Integrative Biology of the Cell (I2BC), CNRS, Université Paris Sud, CEA, F-91405 Orsay, France.
Sandrine Calvet-VitaleUniversité Paris Cité, CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France.ORCID 0000-0003-2135-2083
Michaël BoscoUniversité Paris Cité, CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France.ORCID 0000-0002-6872-3999
Christine Gravier-PelletierUniversité Paris Cité, CNRS, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, F-75006 Paris, France.ORCID 0000-0002-5946-9722
Centre National de la Recherche Scientifique · FRUniversité Paris-Sud · FRUniversity of Liège · BE
Funding
Centre National de la Recherche Scientifique N/AChinese Scholarship Council 201909505005Ministère de l'Enseignement Supérieur et de la Recherche N/A
6 · The paper itself
Abstract
New inhibitors of the bacterial transferase MraY from
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.